MEDISCA White Papers

Discover the in-depth results produced by MEDISCA’s research and development pipeline. These detailed results can help compounding pharmacists to shed light on recent studies and, ultimately, improved patient care.

• Bracketed Stability of Extemporaneously Compounded Omeprazole 2, 5 and 10 mg/mL in Oral Mix Dry Alka, SF (Cherry Flavored)
  (2018)
• Microbiological Stability Testing of Extemporaneously Compounded Omeprazole 2 mg/mL in Oral Mix Dry Alka, SF (Cherry Flavored and Unflavored)
  (2018)
• Parabens: The Importance and Safety of Preservatives
  (2018)
• Why MEDISCA Went Dye-Free
  (2016)
• Comparison of In Vitro Percutaneous Absorption of Compounded Medications in Liposomal vs Non-Liposomal Vehicles.
  (2015)
• In Vitro skin study: Optimized delivery of Diclofenac sodium
  (2015)
• Evaluation of the Inversina Manual Mixer - Powders & Liquids
  (2014)
• In Vitro skin studies of Percutaneous Absorption of (14C)-Progesterone
  (2014)